These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31917296)

  • 1. Ferroptosis-driven nanotherapeutics for cancer treatment.
    Shan X; Li S; Sun B; Chen Q; Sun J; He Z; Luo C
    J Control Release; 2020 Mar; 319():322-332. PubMed ID: 31917296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis-Driven Nanotherapeutics to Reverse Drug Resistance in Tumor Microenvironment.
    Zhu L; Meng D; Wang X; Chen X
    ACS Appl Bio Mater; 2022 Jun; 5(6):2481-2506. PubMed ID: 35614872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron based nanotherapeutics for ferroptosis-induced cancer therapy.
    Liu YM; Chen YH; Jin YC; Tang KZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11323-11333. PubMed ID: 33215452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive metal-containing nanomaterials for ferroptotic cancer therapy.
    Fei W; Zhang Y; Ye Y; Li C; Yao Y; Zhang M; Li F; Zheng C
    J Mater Chem B; 2020 Dec; 8(46):10461-10473. PubMed ID: 33231601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Regulation and Nonepigenetic Mechanisms of Ferroptosis Drive Emerging Nanotherapeutics in Tumor.
    Cheng Y; Xie Y; Chen Y; Liu X
    Oxid Med Cell Longev; 2021; 2021():8854790. PubMed ID: 33574983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting nonapoptotic pathways with functionalized nanoparticles for cancer therapy: current and future perspectives.
    Yadav M; Niveria K; Sen T; Roy I; Verma AK
    Nanomedicine (Lond); 2021 May; 16(12):1049-1065. PubMed ID: 33970686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects.
    Yu S; Tong L; Shen J; Li C; Hu Y; Feng K; Shao J
    Eur J Med Chem; 2024 Apr; 269():116290. PubMed ID: 38518522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
    Xiang D; Zhou L; Yang R; Yuan F; Xu Y; Yang Y; Qiao Y; Li X
    Int J Nanomedicine; 2024; 19():2091-2112. PubMed ID: 38476278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotherapeutics targeting autophagy regulation for improved cancer therapy.
    Liu Y; Wang Y; Zhang J; Peng Q; Wang X; Xiao X; Shi K
    Acta Pharm Sin B; 2024 Jun; 14(6):2447-2474. PubMed ID: 38828133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
    Liang C; Zhang X; Yang M; Dong X
    Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
    Zafar H; Raza F; Ma S; Wei Y; Zhang J; Shen Q
    Biomater Sci; 2021 Aug; 9(15):5092-5115. PubMed ID: 34160488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boarding pyroptosis onto nanotechnology for cancer therapy.
    Ban W; Chen Z; Zhang T; Du T; Huo D; Zhu G; He Z; Sun J; Sun M
    J Control Release; 2024 Jun; 370():653-676. PubMed ID: 38735396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological protein mediated ferroptotic tumor nanotherapeutics.
    Tao J; Li C; Zheng Y; Wang F; Zhang M; Wu X; Chen Y; Zeng Q; Chen F; Fei W
    J Mater Chem B; 2021 Nov; 9(45):9262-9284. PubMed ID: 34730601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy.
    Zheng S; Li G; Shi J; Liu X; Li M; He Z; Tian C; Kamei KI
    J Control Release; 2023 Sep; 361():819-846. PubMed ID: 37597809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis inducers: A new frontier in cancer therapy.
    Ma W; Hu N; Xu W; Zhao L; Tian C; Kamei KI
    Bioorg Chem; 2024 May; 146():107331. PubMed ID: 38579614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of nanoparticles based on ferroptosis in cancer therapy.
    Li Y; Wei C; Yan J; Li F; Chen B; Sun Y; Luo K; He B; Liang Y
    J Mater Chem B; 2024 Jan; 12(2):413-435. PubMed ID: 38112639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging nanotherapeutics for antithrombotic treatment.
    Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
    Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis in cancer therapeutics: a materials chemistry perspective.
    Guan Q; Zhou LL; Dong YB
    J Mater Chem B; 2021 Nov; 9(43):8906-8936. PubMed ID: 34505861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics.
    Chen S; Shi J; Yu D; Dong S
    Biomed Pharmacother; 2024 Jul; 176():116904. PubMed ID: 38878686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in nanotechnology based ferroptotic therapies for clinical applications.
    Xu Y; Qin Z; Ma J; Cao W; Zhang P
    Eur J Pharmacol; 2020 Aug; 880():173198. PubMed ID: 32473167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.